A study in the Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP), published by Elsevier, reports that the type of one-on-one treatment plans delivered to toddlers, aged 12-30 months, diagnosed with autism spectrum disorder (ASD) did not lead to any significantly different outcomes. Neither the type of evidence-based intervention provided, nor the […]
At the current rate of change, it will take more than 200 years for the proportion of women in orthopedic surgery to reach parity with the overall medical profession, according to a study in Clinical Orthopedics and Related Research (CORR), a publication of The Association of Bone and Joint Surgeons. “Substantive changes must be made […]
It can be hard to resist lapsing into an exaggerated, singsong tone when you talk to a cute baby. And that’s with good reason. Babies will pay more attention to baby talk than regular speech, regardless of which languages they’re used to hearing, according to a study by UCLA’s Language Acquisition Lab and 16 other […]
Loose Women: Dr Hilary discusses how to live longer When you subscribe we will use the information you provide to send you these newsletters.Sometimes they’ll include recommendations for other related newsletters or services we offer.Our Privacy Notice explains more about how we use your data, and your rights.You can unsubscribe at any time. There is […]
There were no significant differences in health outcomes for pregnant women who were diagnosed with gestational diabetes or their babies using two different clinically recommended screening methods, according to results from a large-scale clinical trial conducted by Kaiser Permanente researchers and published in The New England Journal of Medicine. Although there is evidence that treating […]
SANTA MONICA, Calif.–(BUSINESS WIRE)–Mar. 5, 2021– Kite, a Gilead Company (Nasdaq: GILD), today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval to Yescarta® (axicabtagene ciloleucel) for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) after two or more lines of systemic therapy. The approval makes Yescarta the first chimeric antigen receptor […]
Collaborating with the University of Oxford, Professor Ho Yin Edwin Chan’s research team from the School of Life Sciences of The Chinese University of Hong Kong (CUHK) recently unveiled the counteracting relationship between pre-mRNA-processing factor 19 (Prpf19) and exocyst complex component 7 (Exoc7) in controlling the degradation of disease protein and neurodegeneration of the rare […]
Human error is a causal factor in up to 80 percent of workplace accidents. A new study measuring the eye movements and cognitive processes for at-risk workers, sheds new light on the potential to avert accidents and possibly prevent workplace injuries. The study “Measuring attention, working memory, and visual perception to reduce risk of injuries […]
Harvard T.H. Chan School of Public Health’s Barry Bloom, Joan L. and Julius H. Jacobson Research Professor of Public Health, offers context about the news that two experimental vaccines appear to confer a high level of protection from the coronavirus. Q&A: Barry Bloom CHAN SCHOOL: Within the space of a week, we’ve heard about not […]
Two independent clinical studies—one by researchers at the Center for Cell-Based Therapy (CTC) in Ribeirão Preto, state of São Paulo (Brazil), on the monoclonal antibody eculizumab, and the other by scientists at the University of Pennsylvania in Philadelphia (U.S.) on an experimental drug called AMY-101—observed a significant anti-inflammatory effect that contributed to a faster recovery […]
